Research study Program year 2020 Source: CMS Open Payments

M19-161

ClinicalTrials.gov NCT04274894

Research payments

$2,814,669

449 payments

Through program year 2020, $2,814,669 in research payments was reported against M19-161, across 449 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT04274894

By program year

1 row

Year	Kind	Amount	Payments
2020	Research	$2,814,669	449

Breakdown

Who paid Research payments · program year 2020

AbbVie, Inc. $2,814,669 449 payments

Who received the money Research payments · program year 2020

Northwest Houston Clinical Research Pllc Organisation paid for research $183,804 13 payments
Indago Research And Health Center INC Organisation paid for research $156,503 8 payments
New Phase Research And Development Organisation paid for research $154,239 22 payments
Accumed Research Associates Organisation paid for research $141,522 9 payments
Burke Internal Medicine INC Organisation paid for research $128,851 12 payments
Valley Renal Medical Group Research Organisation paid for research $114,605 8 payments
North Georgia Clinical Research Inc Organisation paid for research $105,174 6 payments
First Business Growth Funding A Division Of First Business Capital Corp Organisation paid for research $103,887 14 payments
FMC Science LLC Organisation paid for research $99,548 31 payments
West Orange Endocrinology PA Organisation paid for research $98,946 9 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.